Han T, Dadey B, Pollard C, Barcos M, Bloom M L, Minowada J, Ozer H
Blood. 1984 Apr;63(4):958-64.
The malignant monoclonal population in hairy cell leukemia (HCL) has been variously ascribed to be of myeloid, B, or even T cell origin. Recent data have been interpreted as suggesting that hairy cells (HC) may concomitantly or serially express both B and T surface determinants, a phenomenon which, if verified, would be unique among the lymphoproliferative malignancies. Data described here, however, demonstrate that (1) at least the majority of HCL are phenotypically of B cell derivation, and (2) the initial B cell phenotype is retained and solely expressed on cultured as well as phytohemagglutinin (PHA) activated monoclonal malignant HC.
毛细胞白血病(HCL)中的恶性单克隆细胞群曾被认为源自髓系、B细胞甚至T细胞。近期数据表明,毛细胞(HC)可能同时或相继表达B细胞和T细胞表面标志物,若这一现象得到证实,将在淋巴增殖性恶性肿瘤中独一无二。然而,本文所述数据表明:(1)至少大多数HCL在表型上源自B细胞;(2)最初的B细胞表型得以保留,并仅在培养的以及经植物血凝素(PHA)激活的单克隆恶性HC上表达。